Xin Liu | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

 

Best Researcher Award

Xin Liu
Shenyang Agricultural University , China

Xin Liu
Affiliation Shenyang Agricultural University
Country China
Scopus ID 57207948842
Citations 540
h-index 12
Documents 33
Subject Area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0000-0002-4155-9770

Xin Liu is a researcher affiliated with Shenyang Agricultural University, China, specializing in Molecular Biology. The researcher’s academic activities focus on biological mechanisms, molecular studies, and scientific investigations contributing to advancements in life sciences. [1]

Abstract

The Best Researcher Award recognizes scientific contributions, academic excellence, and meaningful advancement within specialized research fields. Xin Liu’s work in Molecular Biology reflects continued participation in research activities supporting biological discoveries and scientific development. [2]

Keywords

  • Molecular Biology
  • Biological Research
  • Genetic Studies
  • Life Science Innovation

Introduction

Molecular Biology examines biological processes at molecular levels, including genetic information, cellular mechanisms, and molecular interactions. Research in this discipline supports developments across biotechnology, medicine, and biological sciences. [3]

Research Profile

Xin Liu has established a research profile in Molecular Biology through scientific publications and scholarly contributions. The researcher has published 33 documents and achieved 540 citations with an h-index of 12, demonstrating engagement with the international research community. [1]

Research Contributions

  • Contribution to molecular and biological research studies.
  • Advancement of knowledge in molecular mechanisms.
  • Support for scientific progress through publications.

Publications

The researcher’s publications contribute to Molecular Biology literature through studies related to biological processes, molecular interactions, and scientific applications. These publications support continued research discussions within life sciences. [4]

Research Impact

Research impact is reflected through scientific output, citations, and contributions to the advancement of knowledge. Xin Liu’s academic record highlights involvement in Molecular Biology research and scholarly communication. [2]

Award Suitability

The Best Researcher Award recognizes researchers whose scientific activities contribute to innovation and academic progress. Xin Liu’s research background and contributions in Molecular Biology align with the objectives of international scientific recognition. [5]

Conclusion

Xin Liu represents a researcher contributing to Molecular Biology through scientific research and academic publications. The researcher’s work supports continued exploration of biological systems and molecular science.

References

  1. Elsevier. (n.d.). Scopus author details: Xin Liu, Author ID 57207948842. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57207948842
  2. ORCID. (n.d.). Xin Liu ORCID Researcher Profile.
    https://orcid.org/0000-0002-4155-9770
  3. Nature Reviews Molecular Cell Biology. (n.d.). Molecular Biology Research Overview.
    https://doi.org/10.1038/s41580-020-00301-7
  4. Oxford Academic. (n.d.). Scientific publications The Plant Cell in molecular biology.
    https://doi.org/10.1016/j.tibtech.2020.05.006
  5. International Molecular Biologist Awards. (n.d.). Award Information Portal.
    https://molecularbiologist.org/

 

Osama A. M. Al-Bedak | Biotechnology | Research Excellence Award

Published on by Molecular Biologist

 

Research Excellence Award

Osama A. M. Al-Bedak
Assiut University , Egypt

Osama A. M. Al-Bedak
Affiliation Assiut University
Country Egypt
Google Scholar ID qj40-r4AAAAJ
Citations 716
h-index 15
i10-index 21
Subject Area Biotechnology
Event International Molecular Biologist Awards
Scopus ID 57200386563
ORCID 0000-0003-0465-619X

Osama A. M. Al-Bedak is a researcher affiliated with Assiut University, Egypt, specializing in Biotechnology. His academic work focuses on biological sciences, biotechnology applications, and research activities that contribute to scientific development and innovation. [1]

Abstract

The Research Excellence Award recognizes scientists who demonstrate academic contribution, innovation, and dedication to advancing knowledge. Osama A. M. Al-Bedak’s research profile in Biotechnology reflects continued involvement in scientific studies and scholarly activities that support progress in biological sciences. [2]

Keywords

  • Biotechnology
  • Molecular Biology
  • Biological Research
  • Scientific Innovation

Introduction

Biotechnology combines biological sciences with technological approaches to develop solutions in medicine, agriculture, industry, and environmental research. Researchers in this discipline contribute to advances in biological understanding and practical applications. [3]

Research Profile

Osama A. M. Al-Bedak has developed an academic profile within Biotechnology through scientific publications and research contributions. His scholarly indicators include 716 citations, an h-index of 15, and an i10-index of 21, demonstrating engagement with research communities. [1]

Research Contributions

  • Contribution to biotechnology research and biological applications.
  • Advancement of knowledge through scientific publications.
  • Research involvement in biological and molecular studies.

Publications

The researcher’s publications contribute to biotechnology literature by supporting scientific discussions related to biological processes, applied research, and technological development. [4]

Research Impact

Research impact is reflected through scholarly output, citations, and contributions to scientific communities. Osama A. M. Al-Bedak’s research record highlights continued participation in Biotechnology research and academic advancement. [2]

Award Suitability

The Research Excellence Award recognizes researchers who contribute meaningful scientific knowledge. Osama A. M. Al-Bedak’s research activities, academic record, and contributions within Biotechnology align with the goals of international scientific recognition. [5]

Conclusion

Osama A. M. Al-Bedak represents a researcher contributing to Biotechnology through scientific investigation and academic publication. His work supports continued development in biological research and innovation.

References

  1. Elsevier. (n.d.). Scopus author details: Osama A. M. Al-Bedak, Author ID 57200386563. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57200386563
  2. ORCID. (n.d.). Osama A. M. Al-Bedak ORCID Researcher Profile.
    https://orcid.org/0000-0003-0465-619X
  3. Google Scholar. (n.d.). Osama A. M. Al-Bedak Scholar Profile.
    https://scholar.google.com.eg/citations?hl=en&user=qj40-r4AAAAJ
  4. Springer Nature. (n.d.). Biotechnology research and applications.
    https://doi.org/10.1038/s41587-020-0501-8
  5. International Molecular Biologist Awards. (n.d.). Award Information Portal.
    https://molecularbiologist.org/

 

Landon Parrow | Molecular Biophysics | Young Scientist Award

Published on by Molecular Biologist

Young Scientist Award

Landon Parrow
University of Mississippi Medical Center

Landon Parrow
Affiliation University of Mississippi Medical Center
Country United States
Documents 2
Subject Area Molecular Biophysics
Event International Molecular Biologist Awards
ORCID 0009-0005-4374-4354

Landon Parrow is an emerging American researcher whose academic activities are centered on molecular biophysics, cardiovascular physiology, aging biology, and metabolic disease research. Through training at Mississippi State University and the University of Mississippi Medical Center, he has contributed to investigations examining mechanisms of cardiac injury, lipid metabolism, fibrosis, and sex-specific physiological responses. His recent scholarly output demonstrates early-career involvement in interdisciplinary biomedical research with relevance to translational medicine and molecular health sciences.[1]

Abstract

This article summarizes the academic profile and research contributions of Landon Parrow in relation to the Young Scientist Award under the International Molecular Biologist Awards. His work focuses on molecular and physiological mechanisms associated with cardiovascular disease, metabolic dysfunction-associated steatotic liver disease, aging biology, and cellular protective pathways. Despite being at an early career stage, he has participated in peer-reviewed research addressing clinically relevant biomedical questions and has contributed to publications in recognized international journals.[2]

Keywords

Molecular Biophysics, Cardiovascular Physiology, Aging Biology, Fibrosis, Metabolic Disease, Biochemistry, Cardioprotection, Biomedical Research.

Introduction

The development of innovative biomedical research depends significantly on the contributions of early-career scientists. Landon Parrow represents a new generation of researchers engaged in exploring molecular and physiological processes underlying disease progression and therapeutic intervention. His academic pathway includes biochemistry training and research appointments associated with cardiovascular and metabolic health investigations.[1]

Research Profile

Parrow earned his academic training in Biochemistry at Mississippi State University and subsequently engaged in research activities at the University of Mississippi Medical Center. His professional progression includes appointments as Junior Researcher and Research Assistant within physiology, biophysics, and biomedical research environments. These experiences have provided opportunities to participate in multidisciplinary projects involving molecular mechanisms of disease and translational biomedical science.[1]

Research Contributions

His research contributions include investigations into cardioprotective mechanisms associated with metabolic disorders and studies examining sex-specific cardiovascular responses during accelerated aging. These projects explore biological pathways influencing lipid accumulation, cardiac fibrosis, oxidative stress regulation, and physiological adaptation. Such work contributes to the broader understanding of cardiovascular health and age-related disease mechanisms.[2][3]

Publications

  • Cardioprotective Effects of 1,3 Butanediol in MASLD via Reversal of Cardiac Lipid Accumulation and Suppression of Cardiac Fibrosis. International Journal of Molecular Sciences (2026).
  • Sex Dimorphism in the Cardiovascular Responses to d-Galactose-Induced Accelerated Aging: Effects of HO-1 Modulation. GeroScience (2026).

Research Impact

Although currently at an early stage of his scholarly career, Parrow’s publications address contemporary biomedical challenges, including cardiovascular complications associated with metabolic disease and biological aging. His participation in peer-reviewed research reflects scientific rigor and a commitment to advancing knowledge relevant to molecular medicine and physiological health.[2][3]

Award Suitability

The Young Scientist Award recognizes promising researchers who demonstrate academic excellence, research productivity, and future leadership potential. Based on his educational achievements, research appointments, and peer-reviewed publications in internationally recognized journals, Landon Parrow demonstrates characteristics aligned with the objectives of this recognition. His work contributes to emerging knowledge in molecular biophysics and biomedical science while supporting ongoing advancements in translational research.[4]

Conclusion

Landon Parrow has established an encouraging foundation for a research career focused on molecular and physiological mechanisms of disease. Through contributions to studies involving cardiovascular pathology, metabolic dysfunction, and aging biology, he has demonstrated scientific engagement and potential for future impact. His profile represents the qualities typically associated with promising early-career investigators in the biomedical sciences.

References

  1. ORCID. (2026). Landon Parrow: Employment history, education, and professional profile.
    https://orcid.org/0009-0005-4374-4354
  2. Parrow, L., et al. (2026). Cardioprotective Effects of 1,3 Butanediol in MASLD via Reversal of Cardiac Lipid Accumulation and Suppression of Cardiac Fibrosis. International Journal of Molecular Sciences.
    DOI:https://doi.org/10.3390/ijms27125354
  3. Parrow, L., et al. (2026). Sex Dimorphism in the Cardiovascular Responses to d-Galactose-Induced Accelerated Aging: Effects of HO-1 Modulation. GeroScience.
    DOI:https://doi.org/10.1007/S11357-026-02165-3
  4. International Molecular Biologist Awards. (2026). Young Scientist Award criteria and recognition framework.
    molecularbiologist.org
  5. Elsevier. (n.d.). Scopus author details: Landon Parrow
  6. University of Mississippi Medical Center. (2026). Research and academic activities in Physiology and Biophysics.

Zhongxiang He | Molecular Biology | Research Excellence Award

Published on by Molecular Biologist

Dr. Zhongxiang He | Molecular Biology | Research Excellence Award

Dr. Zhongxiang He | Guizhou university | China

Dr. Zhongxiang He is an emerging researcher specializing in secure data systems and intelligent healthcare technologies. His work focuses on advanced encryption methods, privacy-preserving frameworks, and robust medical image watermarking using innovative models such as wavelet-driven architectures. He has contributed to interdisciplinary research in cloud-enabled e-health systems and information security, aiming to enhance data integrity, traceability, and confidentiality. His publications reflect a growing impact in applied cryptography and computational intelligence for real-world healthcare and digital security applications.

Research Metrics

50

40

30

20

10

0

Citations
3

Documents
2

h-index
1

        🟦 Citations    🟥 Documents    🟩 h-index


View ORCID Profile

Featured Publications

Maryam Sharzehee | Molecular Biology | Excellence in Research Award

Published on by Molecular Biologist

Assist. Prof. Dr. Maryam Sharzehee | Molecular Biology | Excellence in Research Award 

Lecturer | Yazd University | Iran

Assist. Prof. Dr. Maryam Sharzehee is a distinguished textile engineering scholar specializing in textile chemistry, advanced finishing technologies, and functional polymer systems. She focuses on innovative and sustainable textile materials, including antibacterial and flame-retardant treatments, nano-enabled and smart textiles, functional hydrogels, and polymer-based medical and bio-textiles. Her research emphasizes environmentally friendly chemical finishing agents and practical applications in textile science. Dr. Sharzehee’s work is internationally recognized through publications in high-impact journals, invited conference presentations, and applied research contributions. To date, she has authored 15 documents, cited 67 times, with an h-index of 5, demonstrating her significant impact in textile engineering.

 

Citation Metrics (Scopus)

80
60
40
20
0

Citations
67

Documents
15

h-index
5

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile
 View Google Scholar Author Profile

Featured Publications

Sooyoung Kim | Molecular Biology | Editorial Board Member

Published on by Molecular Biologist

Dr. Sooyoung Kim | Molecular Biology | Editorial Board Member

Industry | US Neurophth Therapeutics (Ex-) | United States

Soo-Young Kim is an accomplished researcher specializing in retinal biology, neurodegeneration, and therapeutic development for ocular diseases. He holds a PhD in Medicine from Korea University and has extensive experience across academia and industry, including positions at UC Irvine, Neurophth Therapeutics, ExosomePlus, Johns Hopkins Wilmer Eye Institute, and the National Eye Institute. His research focuses on retinal development, age-related macular degeneration, and neovascularization, with significant contributions to understanding photoreceptor synapse formation, retinal degeneration models, and inflammatory pathways in pathological neovascularization. Kim has authored numerous publications in high-impact journals, advancing both basic science and translational applications in ophthalmology. His work combines molecular, cellular, and whole-mount techniques to elucidate disease mechanisms and support drug evaluation, reflecting a strong commitment to bridging experimental research with therapeutic innovation.

Profile: ORCID

Featured Publications

Kim, S.-Y., Park, C. H., Moon, B.-H., & Seabold, G. K. Murine Retina Outer Plexiform Layer Development and Transcriptome Analysis of Pre-Synapses in Photoreceptors. Life, 14(9), 1103.

Moon, B.-H., Kim, Y., & Kim, S.-Y. Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment. International Journal of Molecular Sciences, 24(16), 13004.

Kim, S.-Y., & Qian, H. Comparison between sodium iodate and lipid peroxide murine models of age-related macular degeneration for drug evaluation—a narrative review. Annals of Eye Science, 7, Article 25.

Kim, S.-Y., Zhao, Y., Kim, H.-L., Oh, Y., & Xu, Q. Sodium iodate-induced retina degeneration observed in non-separate sclerochoroid/retina pigment epithelium/retina whole mounts. Annals of Eye Science, 7, Article 27.

Lee, S.-J., & Kim, S.-Y. Mouse Sclerochoroid/RPE/Retina posterior eyeball staining and Whole Mounts. BIO-PROTOCOL, 11(15), e3872.

Kim, S.-Y. Inflammatory pathways in pathological neovascularization in retina and choroid: a narrative review on the inflammatory drug target molecules in retinal and choroidal neovascularization. Annals of Eye Science, 6, Article 4.

Georges Nemer | Molecular Biology | Editorial Board Member

Published on by Molecular Biologist

Prof. Georges Nemer | Molecular Biology | Editorial Board Member 

Professor | Hamad Bin Khalifa University | Qatar

Dr. Georges Nemer is a prominent molecular cardiology and biomedical research expert whose work spans cardiac development, congenital heart defects, transcriptional regulation, and translational molecular biology. His research has uncovered key mechanisms governing cardiogenesis, including defining the role of the T-box transcription factor Tbx5 in heart formation and disease, demonstrating how GATA-4 overexpression enhances cardiogenesis in embryonic stem cells, and revealing the cooperative regulation of myocardial gene expression by GATA-4 and GATA-6. Dr. Nemer has also contributed to clinical genetics through the identification of novel GATA4 mutations associated with Tetralogy of Fallot, supporting improved understanding of congenital heart malformations. Beyond cardiology, his scholarship extends to dermatological science, elucidating molecular pathways and clinical applications of retinoids, and to computational biochemistry through work on protein-ligand docking using AutoDock for targets such as BACE1. His interdisciplinary portfolio reflects a commitment to bridging basic science and clinical relevance, advancing knowledge across cardiac biology, human genetics, molecular therapeutics, and biomedical modeling.

Profile: Google Scholar

Featured Publications

Bruneau, B. G., Nemer, G., Schmitt, J. P., Charron, F., Robitaille, L., Caron, S., …
(2001). A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell, 106(6), 709–721.

Grépin, C., Nemer, G., & Nemer, M. (1997). Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development, 124(12), 2387–2395.

Charron, F., Paradis, P., Bronchain, O., Nemer, G., & Nemer, M. (1999). Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Molecular and Cellular Biology, 19(6), 4355–4365.

Khalil, S., Bardawil, T., Stephan, C., Darwiche, N., Abbas, O., Kibbi, A. G., …
(2017). Retinoids: A journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. Journal of Dermatological Treatment, 28(8), 684–696.

Nemer, G., Fadlalah, F., Usta, J., Nemer, M., Dbaibo, G., Obeid, M., & Bitar, F. (2006). A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Human Mutation, 27(3), 293–294.

El-Hachem, N., Haibe-Kains, B., Khalil, A., Kobeissy, F. H., & Nemer, G. (Year unavailable). AutoDock and AutoDockTools for protein-ligand docking: Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study. Neuroproteomics: Methods and Protocols, 391–403.

Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award 

Doctorate | ICOA | France

Dr. Rouba Nasreddine is an accomplished Lebanese-French scientist and Associate Professor at the University of Orléans, France, specializing in analytical chemistry and environmental analysis. She is a member of the Analytical Strategies, Affinities and Bioactives (SAAB) research team at the Institute of Organic and Analytical Chemistry (ICOA), where her work bridges analytical innovation and environmental sustainability through advanced detection methods for bioaerosols and volatile organic compounds. Her research contributions extend across chromatography, spectroscopy, and microscale thermophoresis, with a focus on enzyme dynamics and molecular affinities in complex environments. She has published 19 scientific documents, cited 327 times across 283 sources, and holds an h-index of 11, reflecting her growing impact in the field. Dr. Nasreddine’s interdisciplinary collaborations and teaching at the University Institute of Technology of Orléans continue to inspire innovation in analytical science and sustainable chemistry.

Profile: Scopus | ORCID

Featured Publications

Nasreddine, R., et al. (2025). Molecules, 30, 4008. [Cited by 12 articles]

Kharrat, O., et al. (2025). PNAS, 122, e2415524122. [Cited by 24 articles]

Kharrat, O., et al. (2025). J. Biol. Chem., 301, 110587. [Cited by 16 articles]

Chartier, S., et al. (2025). Analytica Chimica Acta, 1360, 344145. [Cited by 8 articles]

Quinty, V., et al. (2023). Food Bioscience, 55, 103069. [Cited by 20 articles]

Shangze Li | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Shangze Li | Molecular Biology | Best Researcher Award 

Assistant to the Dean | Chongqing University | China

Dr. Shangze Li (Ph.D., Associate Professor, Ph.D. Supervisor) is a distinguished researcher in the fields of antiviral innate immune signaling, inflammatory responses, and tumor biology. He is based at the School of Medicine, Chongqing University, where he leads a research group and supervises doctoral students. His work integrates advanced genetic engineering technologies such as gene knockout, knock-in approaches, and disease models to investigate the molecular basis of immune regulation and cancer development. Dr. Li has published extensively in leading international journals including Nature Communications, Cell Death and Differentiation, Cancer Research, Oncogene, and Cancer Letters, with several contributions featured in Nature Index journals. His studies have been widely cited, reflecting both scientific impact and relevance to the global biomedical community. In addition to research, he is actively involved in teaching, mentoring, editorial service, and academic leadership, contributing to the advancement of both education and medical research.

Professional Profile

Scopus

ORCID

Google Scholar

Education 

Dr. Li completed his doctoral degree in Cell Biology at Wuhan University, where he focused on the molecular mechanisms that link immune regulation to tumorigenesis. Prior to his doctoral training, he pursued two undergraduate degrees, one in Bioengineering from the Chengdu University of Technology and another in Business Administration from the University of Electronic Science and Technology of China. This unique combination of scientific and managerial education provided him with both technical expertise and leadership skills. After completing his doctorate, Dr. Li undertook postdoctoral training at the Feinberg School of Medicine, Northwestern University, where he worked on projects exploring molecular oncology, innate immunity, and translational approaches in cancer research. His diverse academic background, spanning engineering, business, molecular biology, and medical research, has prepared him to integrate interdisciplinary knowledge in his career. This foundation continues to guide his role as a scientist, supervisor, and contributor to medical and biological sciences.

Experience 

Dr. Li began his professional research career at the Feinberg School of Medicine, Northwestern University, where he served as a postdoctoral researcher in molecular oncology and immune regulation. Following this period of international training, he returned to China and accepted an appointment at Zhongnan Hospital of Wuhan University and the College of Life Sciences, where he contributed to teaching and research in biomedical sciences. He later joined the School of Medicine at Chongqing University as a faculty member, where he was subsequently promoted to Associate Professor and Ph.D. Supervisor. In this role, he leads a laboratory focused on investigating immune signaling and cancer development. In addition to his research and teaching, Dr. Li has taken on administrative responsibilities, serving as Assistant to the Dean and Deputy Director of Shared Core Facilities for Medical Research. His experience reflects a career that balances leadership, education, and internationally recognized scientific research.

Research Interests 

Dr. Li’s research centers on the molecular mechanisms of innate immune signaling, inflammation, and tumor biology. His work explores how signaling pathways regulate immune homeostasis and contribute to tumor initiation and progression. He employs genetically modified cell lines, CRISPR-based technologies, and animal models to examine the functional roles of key genes in these processes. His studies often focus on ubiquitination and deubiquitination pathways, NF-κB signaling, and the crosstalk between cellular metabolism and cell death. This approach provides critical insights into how molecular dysregulation drives oncogenesis and resistance to therapy. His research also emphasizes translational applications, identifying potential biomarkers and therapeutic strategies that may guide novel approaches in cancer treatment and immune-related diseases. By integrating molecular biology, immunology, and cancer research, Dr. Li contributes to advancing both fundamental scientific knowledge and practical innovations for improving health outcomes.

Awards 

Dr. Li’s research achievements have been recognized through broad citation and publication in top international journals. His scholarly contributions have been acknowledged in Nature Communications, Molecular Cancer, Cancer Research, and other leading journals, with some articles featured as cover stories in Nature Index publications. His body of work has earned substantial recognition in the scientific community, reflected in a strong citation record and consistent invitations to review for leading journals. He has also served as Guest Editor for Vaccines and as a reviewer for the National Natural Science Foundation of China, underscoring his role as a trusted scientific evaluator. Beyond research output, Dr. Li has contributed actively to professional organizations, including serving as a council member of the Chongqing Association of Young Scientists and participating in national academic initiatives. His record demonstrates recognition for both scholarly impact and professional service, positioning him as a strong candidate for scientific honors.

Top Noted Publications 

Dr. Li has authored more than forty peer-reviewed publications, including a substantial number as first or corresponding author. His research has appeared in high-impact journals such as Nature Communications, Molecular Cancer, Oncogene, Cancer Research, and Cancer Letters. Selected publications include Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression in Cells, CLK2 mediates NF-κB regulation in Nature Communications, Crosstalk between metabolism and cell death in tumorigenesis in Molecular Cancer, USP14 promotes colorectal cancer progression in Cell Death & Disease, and MAPK signaling and drug resistance in prostate cancer in Cancer Research. These publications reflect his long-term focus on the molecular basis of immune regulation and cancer biology. His findings have been widely cited and have advanced understanding of tumorigenesis, therapeutic resistance, and immunoregulation. Collectively, his research portfolio highlights his contributions to both fundamental science and translational medicine, strengthening his standing as an influential scholar in the field of biomedical research.

Title: Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression
Journal: Cells
Year: 2024
Cited by: 15+

Title: CLK2 mediates IkappaBalpha-independent NF-κB regulation
Journal: Nature Communications
Year: 2024
Cited by: 30+

Title: Crosstalk between metabolism and cell death in tumorigenesis
Journal:  Molecular Cancer
Year: 2024
Cited by: 40+

Title: USP14 promotes colorectal cancer progression
Journal: Cell Death & Disease
Year: 2023
Cited by: 25+

Title: Activation of MAPK by CXCR7 causes drug resistance
Journal: Cancer Research
Year: 2019
Cited by: 200+

Conclusion

Dr. Shangze Li is a highly suitable candidate for the Best Researcher Award. His outstanding research achievements, strong academic influence, and balanced contributions to teaching, mentorship, and professional service highlight his excellence as a scholar. With continued focus on international collaboration, high-impact publications, and global leadership roles, he is exceptionally well-positioned to be recognized with this award.

Foziljon Saitkulov | Biochemistry | Best Researcher Award

Published on by Molecular Biologist

Assist. Prof. Dr. Foziljon Saitkulov | Biochemistry | Best Researcher Award 

Assistant professor, at tashkent state agrarian university, Uzbekistan.

Dr. Saitkulov Foziljon Ergashevich, born on May 22, 1976, in Uzbekistan, is a distinguished organic chemist with over two decades of experience in academia and research. Currently serving as a PhD Associate Professor at Tashkent State Agrarian University, he has authored more than 120 scientific articles and theses, along with approximately 10 textbooks and training manuals. His expertise encompasses the synthesis of over 20 organic compounds and a patent in anthelmintic properties. Proficient in modern physical research instruments like ionometers, gas chromatographs, and infrared spectroscopes, Dr. Saitkulov is fluent in Russian, English, and Farsi. His dedication to science and education has significantly contributed to the field of organic chemistry in Uzbekistan.

Professional Profile

Scopus

ORCID​

🎓 Education 

Dr. Saitkulov’s academic journey began at Samarkand State University, where he earned his Bachelor’s degree in Chemistry in 2001. He further pursued a Master’s degree in Organic Chemistry at the same institution, graduating in 2006. His rigorous academic training laid a strong foundation for his future research endeavors. Throughout his studies, he developed a keen interest in heterocyclic compounds and their biological activities, which became the focal point of his subsequent research. His educational background has been instrumental in shaping his career as a researcher and educator in organic chemistry.​http://generis-publishing.com/

💼 Experience 

Dr. Saitkulov commenced his professional career as a teacher at Urgut District School No. 78 from 2001 to 2004. He then served as an assistant at Samarkand State University from 2006 to 2016, where he contributed to various research projects. From 2016 to 2020, he was a researcher at the Chemistry of Plant Substances Institute of the Academy of Sciences of the Republic of Uzbekistan. Since 2020, he has been affiliated with Tashkent State Agrarian University, progressing from assistant to senior teacher, and currently holds the position of PhD Associate Professor. His responsibilities have included teaching organic chemistry, supervising research, and developing educational materials.​

🔬 Research Interests 

Dr. Saitkulov’s research interests are centered around the synthesis and study of heterocyclic compounds, particularly quinazolin-4-one derivatives. He investigates their biological activities, including potential anthelmintic properties. His work involves exploring the biochemical effects of coordination compounds and their applications in agriculture and medicine. He is also interested in the development of environmentally friendly fertilizers and the analysis of plant-based compounds using advanced spectroscopic methods. His research contributes to the understanding of organic compounds’ roles in various biological processes.​ResearchGate+6http://generis-publishing.com/+6LIBROTERRA+6Premier Publishing

🏆 Awards

Dr. Saitkulov has been recognized for his significant contributions to organic chemistry through various awards and honors. His innovative research on quinazolin-4-one derivatives and their biological activities has garnered attention in scientific circles. He has received accolades for his publications and presentations at national and international conferences. His dedication to teaching and mentoring students has also been acknowledged by academic institutions. These awards reflect his commitment to advancing the field of organic chemistry and his impact on scientific research and education.​

📚Top Noted Publications 

Dr. Saitkulov has an extensive publication record, including over 120 scientific articles and theses. Notable publications include:​

1. Synthesis and Study of the Processes of Biochemical Action of the Coordination Compound of Cobalt(II) Nitrate Quinazolin-4-One with 3-Indolyl Acetic Acid in Amber Plants

  • Authors: [Add if applicable]

  • Year: 2022

  • Publisher: Premier Publishing

  • Summary: This work explores the synthesis of a cobalt(II) nitrate coordination compound with quinazolin-4-one and its biochemical action in Amber plants, focusing on potential growth stimulation via interaction with 3-indolyl acetic acid (a known auxin).

  • Indexing/Availability: ResearchGate [+1]

2. Synthesis of Stimulants Based on Heterocyclic Compounds Quinazolin-4-One

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: LIBROTERRA

  • Summary: This study focuses on the design and chemical synthesis of stimulants using quinazolin-4-one as a heterocyclic scaffold, with possible applications in plant growth regulation or pharmaceutical precursors.

  • Indexing/Availability:

    • Zien Journals [+6]

    • ResearchGate [+6]

3. Investigation of Aromatic Properties of Xinazolin-4-One

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: Premier Publishing

  • Summary: Focused on the structural and electronic aromatic characteristics of “Xinazolin-4-One” (presumably a structural analog or variation of quinazolin-4-one), this work includes computational or spectroscopic analysis to characterize aromatic stability.

  • Indexing/Availability: [Add source or DOI if available]

4. Synthesis of Some Quinazolin-4-One Series Heterocyclic Compounds and Their Biological Activities

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: LIBROTERRA

  • Summary: This paper details the synthetic pathways of multiple quinazolin-4-one derivatives and evaluates their biological properties, potentially including antimicrobial or growth-promoting activities.

  • Also available via: Generis Publishing [+1]

Conclusion

Dr. Saitkulov Foziljon Ergashevich is a strong candidate for the Best Researcher Award, with substantial contributions to organic chemistry research and education over two decades. His track record of publication, compound synthesis, and educational resource development speaks to both academic rigor and real-world impact. With increased international exposure and research collaborations, he holds great potential to further enhance his scientific influence. Therefore, he is well-suited for recognition through this award, especially in categories emphasizing national leadership, innovation, and dedication to chemical sciences.